232 related articles for article (PubMed ID: 27599186)
1. Targeting biomolecules with reversible covalent chemistry.
Bandyopadhyay A; Gao J
Curr Opin Chem Biol; 2016 Oct; 34():110-116. PubMed ID: 27599186
[TBL] [Abstract][Full Text] [Related]
2. Versatile Bioconjugation Chemistries of ortho-Boronyl Aryl Ketones and Aldehydes.
Cambray S; Gao J
Acc Chem Res; 2018 Sep; 51(9):2198-2206. PubMed ID: 30110146
[TBL] [Abstract][Full Text] [Related]
3. Emerging and Re-Emerging Warheads for Targeted Covalent Inhibitors: Applications in Medicinal Chemistry and Chemical Biology.
Gehringer M; Laufer SA
J Med Chem; 2019 Jun; 62(12):5673-5724. PubMed ID: 30565923
[TBL] [Abstract][Full Text] [Related]
4. Application of Dually Activated Michael Acceptor to the Rational Design of Reversible Covalent Inhibitor for Enterovirus 71 3C Protease.
Ma Y; Li L; He S; Shang C; Sun Y; Liu N; Meek TD; Wang Y; Shang L
J Med Chem; 2019 Jul; 62(13):6146-6162. PubMed ID: 31184893
[TBL] [Abstract][Full Text] [Related]
5. A Fast Ab Initio Predictor Tool for Covalent Reactivity Estimation of Acrylamides.
Palazzesi F; Grundl MA; Pautsch A; Weber A; Tautermann CS
J Chem Inf Model; 2019 Aug; 59(8):3565-3571. PubMed ID: 31246457
[TBL] [Abstract][Full Text] [Related]
6. Reversible targeting of noncatalytic cysteines with chemically tuned electrophiles.
Serafimova IM; Pufall MA; Krishnan S; Duda K; Cohen MS; Maglathlin RL; McFarland JM; Miller RM; Frödin M; Taunton J
Nat Chem Biol; 2012 Apr; 8(5):471-6. PubMed ID: 22466421
[TBL] [Abstract][Full Text] [Related]
7. Expanding the Armory: Predicting and Tuning Covalent Warhead Reactivity.
Lonsdale R; Burgess J; Colclough N; Davies NL; Lenz EM; Orton AL; Ward RA
J Chem Inf Model; 2017 Dec; 57(12):3124-3137. PubMed ID: 29131621
[TBL] [Abstract][Full Text] [Related]
8. Recent progress in covalent warheads for in vivo targeting of endogenous proteins.
Shindo N; Ojida A
Bioorg Med Chem; 2021 Oct; 47():116386. PubMed ID: 34509863
[TBL] [Abstract][Full Text] [Related]
9. Dynamic Covalent Chemistry within Biphenyl Scaffolds: Reversible Covalent Bonding, Control of Selectivity, and Chirality Sensing with a Single System.
Ni C; Zha D; Ye H; Hai Y; Zhou Y; Anslyn EV; You L
Angew Chem Int Ed Engl; 2018 Jan; 57(5):1300-1305. PubMed ID: 29239090
[TBL] [Abstract][Full Text] [Related]
10. Arylfluorosulfate-Based Electrophiles for Covalent Protein Labeling: A New Addition to the Arsenal.
Martín-Gago P; Olsen CA
Angew Chem Int Ed Engl; 2019 Jan; 58(4):957-966. PubMed ID: 30024079
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of Mcl-1 through covalent modification of a noncatalytic lysine side chain.
Akçay G; Belmonte MA; Aquila B; Chuaqui C; Hird AW; Lamb ML; Rawlins PB; Su N; Tentarelli S; Grimster NP; Su Q
Nat Chem Biol; 2016 Nov; 12(11):931-936. PubMed ID: 27595327
[TBL] [Abstract][Full Text] [Related]
12. Characterization of Covalent-Reversible EGFR Inhibitors.
Smith S; Keul M; Engel J; Basu D; Eppmann S; Rauh D
ACS Omega; 2017 Apr; 2(4):1563-1575. PubMed ID: 29963651
[TBL] [Abstract][Full Text] [Related]
13. The expanding repertoire of covalent warheads for drug discovery.
Mehta NV; Degani MS
Drug Discov Today; 2023 Dec; 28(12):103799. PubMed ID: 37839776
[TBL] [Abstract][Full Text] [Related]
14. Emerging and Re-emerging Warheads for Targeted Covalent Inhibitors: An Update.
Hillebrand L; Liang XJ; Serafim RAM; Gehringer M
J Med Chem; 2024 May; 67(10):7668-7758. PubMed ID: 38711345
[TBL] [Abstract][Full Text] [Related]
15. Covalent inhibitor reactivity prediction by the electrophilicity index-in and out of scope.
Hermann MR; Pautsch A; Grundl MA; Weber A; Tautermann CS
J Comput Aided Mol Des; 2021 Apr; 35(4):531-539. PubMed ID: 33015740
[TBL] [Abstract][Full Text] [Related]
16. Covalent peptides and proteins for therapeutics.
Berdan VY; Klauser PC; Wang L
Bioorg Med Chem; 2021 Jan; 29():115896. PubMed ID: 33285408
[TBL] [Abstract][Full Text] [Related]
17. Recent advances in dynamic covalent chemistry.
Jin Y; Yu C; Denman RJ; Zhang W
Chem Soc Rev; 2013 Aug; 42(16):6634-54. PubMed ID: 23749182
[TBL] [Abstract][Full Text] [Related]
18. Electrophilic warheads in covalent drug discovery: an overview.
Péczka N; Orgován Z; Ábrányi-Balogh P; Keserű GM
Expert Opin Drug Discov; 2022 Apr; 17(4):413-422. PubMed ID: 35129005
[TBL] [Abstract][Full Text] [Related]
19. Covalent Versus Non-covalent Enzyme Inhibition: Which Route Should We Take? A Justification of the Good and Bad from Molecular Modelling Perspective.
Aljoundi A; Bjij I; El Rashedy A; Soliman MES
Protein J; 2020 Apr; 39(2):97-105. PubMed ID: 32072438
[TBL] [Abstract][Full Text] [Related]
20. Applications of reversible covalent chemistry in analytical sample preparation.
Siegel D
Analyst; 2012 Dec; 137(23):5457-82. PubMed ID: 23013801
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
